Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CSTL Castle Biosciences, Inc.

休市中 12-05 16:00:00 EST

38.64

-0.98

-2.47%

盘后38.64

+0.000.00%

17:01 EST

最高40.10	最低38.38	成交量54.98万
今开39.54	昨收39.62	日振幅4.34%
总市值11.28亿	流通市值10.33亿	总股本2,919万
成交额2,137万	换手率2.06%	流通股本2,672万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CSTL","market":"US","secType":"STK","nameCN":"Castle Biosciences, Inc.","latestPrice":38.64,"timestamp":1764968400000,"preClose":39.62,"halted":0,"volume":549827,"hourTrading":{"tag":"盘后","latestPrice":38.64,"preClose":38.64,"latestTime":"17:01 EST","volume":11607,"amount":448494.48,"timestamp":1764972076474},"delay":0,"floatShares":26724873,"shares":29188659,"eps":-0.434162,"marketStatus":"休市中","change":-0.98,"latestTime":"12-05 16:00:00 EST","open":39.54,"high":40.1,"low":38.38,"amount":21373095.0748,"amplitude":0.043412,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.434162,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1564027200000,"exchange":"NASDAQ","adjPreClose":39.62,"preHourTrading":{"tag":"盘前","latestPrice":39.5,"preClose":39.62,"latestTime":"06:15 EST","volume":70,"amount":2765.19999,"timestamp":1764933310163},"postHourTrading":{"tag":"盘后","latestPrice":38.64,"preClose":38.64,"latestTime":"17:01 EST","volume":11607,"amount":448494.48,"timestamp":1764972076474},"volumeRatio":1.7520234273113615,"impliedVol":0.5257,"impliedVolPercentile":0.284},"requestUrl":"/m/hq/s/CSTL","defaultTab":"news","newsList":[{"id":"1157632361","title":"SciBase与Castle Biosciences扩大合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1157632361","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157632361?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:06","pubTimestamp":1763572016,"startTime":"0","endTime":"0","summary":"11月7日（路透社）- SciBase Holding AB（公开）宣布：*SciBase与Castle Biosciences扩大合作并签署许可协议，同时达成2000万瑞典克朗的贷款协议*Castle将向SciBase提供2000万瑞典克朗的贷款。*贷款以对SciBase股份的质押作为担保。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"1172425872","title":"新数据确认Decisiondx®-Melanoma在识别淋巴结阳性风险低于5%的患者中的表现","url":"https://stock-news.laohu8.com/highlight/detail?id=1172425872","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172425872?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:01","pubTimestamp":1763121687,"startTime":"0","endTime":"0","summary":"新数据确认Decisiondx®-Melanoma在识别淋巴结阳性风险低于5%的患者中的表现","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"1175521487","title":"SciBase与Castle Biosciences扩大合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1175521487","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175521487?lang=zh_cn&edition=full","pubTime":"2025-11-07 15:29","pubTimestamp":1762500579,"startTime":"0","endTime":"0","summary":"11月7日 - SciBase Holding AB（上市公司）宣布：*SciBase与Castle Biosciences扩大合作及许可协议，并签订2000万瑞典克朗的贷款协议。*Castle将向SciBase提供2000万瑞典克朗的贷款。*该贷款由SciBase的股票质押作担保。*","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"1181352573","title":"Scibase与Castle Biosciences扩大合作与许可协议，并签订2000万瑞典克朗借款协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1181352573","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181352573?lang=zh_cn&edition=full","pubTime":"2025-11-07 15:29","pubTimestamp":1762500548,"startTime":"0","endTime":"0","summary":"Scibase与Castle Biosciences扩大合作与许可协议，并签订2000万瑞典克朗借款协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"1154815250","title":"异动解读 | 分析师上调目标价，Castle Biosciences盘中大涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154815250","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154815250?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:48","pubTimestamp":1762267696,"startTime":"0","endTime":"0","summary":"Castle Biosciences, Inc.今日盘中股价大涨6%，引发市场关注。这一显著涨幅主要受到华尔街分析师积极评估的推动。据报道，投资银行Leerink Partners上调了对Castle Biosciences的目标股价，从此前的35美元提高至40美元。Castle Biosciences是一家专注于皮肤癌诊断的生物技术公司。分析师目标价的上调通常会被投资者视为积极信号，认为公司的内在价值可能被低估。这种观点的转变促使更多投资者买入该股，从而推动股价上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSTL"],"gpt_icon":0},{"id":"1129464401","title":"SciBase从Castle Biosciences获得临床研究初始订单","url":"https://stock-news.laohu8.com/highlight/detail?id=1129464401","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129464401?lang=zh_cn&edition=full","pubTime":"2025-09-23 14:21","pubTimestamp":1758608500,"startTime":"0","endTime":"0","summary":"9月23日 - SciBase Holding AB (publ)从Castle Biosciences获得临床研究初始订单。\n该订单包括Nevisense GO设备和电极，价值约80万美元或约800万瑞典克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2558869259","title":"Castle Biosciences, Inc.8月11日成交额为867.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558869259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558869259?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:51","pubTimestamp":1754963500,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Castle Biosciences, Inc.成交额为867.07万美元，成交额较昨日减少21.55%，当日成交量为45.29万股。Castle Biosciences, Inc.于2025年8月11日跌1.03%，报19.16美元，该股过去5个交易日涨25.07%，年初至今跌28.11%，过去60日涨17.4%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|867.07万|-21.55%|45.29万|#|2025-08-08|1105.25万|-22.29%|56.08万|#|2025-08-07|1422.26万|-43.32%|73.81万|#|2025-08-06|2509.12万|-39.52%|127.45万|#|2025-08-05|4148.44万|209.71%|202.49万|Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095153a6e093bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095153a6e093bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2558694503","title":"Castle Biosciences, Inc.8月8日成交额为1105.25万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558694503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558694503?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:51","pubTimestamp":1754704306,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Castle Biosciences, Inc.成交额为1105.25万美元，成交额较昨日减少22.29%，当日成交量为56.08万股。Castle Biosciences, Inc.于2025年8月8日跌1.48%，报19.36美元，该股过去5个交易日涨32.15%，年初至今跌27.35%，过去60日涨13.68%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|1105.25万|-22.29%|56.08万|#|2025-08-07|1422.26万|-43.32%|73.81万|#|2025-08-06|2509.12万|-39.52%|127.45万|#|2025-08-05|4148.44万|209.71%|202.49万|#|2025-08-04|1339.45万|114.83%|88.42万|Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095147a6dbe6fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095147a6dbe6fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2557164825","title":"Castle Biosciences, Inc.8月7日成交额为1422.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557164825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557164825?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:50","pubTimestamp":1754617827,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Castle Biosciences, Inc.成交额为1422.26万美元，成交额较昨日减少43.32%，当日成交量为73.81万股。Castle Biosciences, Inc.于2025年8月7日跌0.56%，报19.65美元，该股过去5个交易日涨29.7%，年初至今跌26.27%，过去60日涨15.32%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|1422.26万|-43.32%|73.81万|#|2025-08-06|2509.12万|-39.52%|127.45万|#|2025-08-05|4148.44万|209.71%|202.49万|#|2025-08-04|1339.45万|114.83%|88.42万|#|2025-08-01|623.49万|-11.50%|42.16万|Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808095032a6d9dcee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808095032a6d9dcee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2557584168","title":"Castle Biosciences, Inc.8月6日成交额为2509.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557584168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557584168?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:48","pubTimestamp":1754531329,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Castle Biosciences, Inc.成交额为2509.12万美元，成交额较昨日减少39.52%，当日成交量为127.45万股。Castle Biosciences, Inc.于2025年8月6日跌2.9%，报19.76美元，该股过去5个交易日涨22.89%，年初至今跌25.85%，过去60日涨17.69%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|2509.12万|-39.52%|127.45万|#|2025-08-05|4148.44万|209.71%|202.49万|#|2025-08-04|1339.45万|114.83%|88.42万|#|2025-08-01|623.49万|-11.50%|42.16万|#|2025-07-31|704.54万|25.52%|45.56万|Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094852a479c4c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094852a479c4c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2557513303","title":"Castle Biosciences, Inc.盘中异动 急速跳水5.04%报19.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557513303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557513303?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:27","pubTimestamp":1754490469,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时27分，Castle Biosciences, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报19.33美元/股，成交量34.1978万股，换手率1.18%，振幅6.99%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为1.39%。其相关个股中，万基遗传、Mdxhealth Sa、Biodesix, Inc.涨幅较大，万基遗传、Applied Dna Sciences, Inc.、Advanced Biomed Inc.较为活跃，换手率分别为6.47%、5.51%、1.83%，振幅较大的相关个股有万基遗传、Biodesix, Inc.、Personalis, Inc.，振幅分别为14.47%、10.40%、8.69%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622274994d391fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622274994d391fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2557336436","title":"Castle Biosciences, Inc.盘中异动 快速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557336436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557336436?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:16","pubTimestamp":1754334976,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时16分，Castle Biosciences, Inc.股票出现异动，股价急速上涨5.19%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为4.06%。其相关个股中，Genedx Holdings Corp C/Wts 22/07/2026 、爱德士、燃石医学涨幅较大，Mainz Biomed N.V.、Applied Dna Sciences, Inc.、Twist Bioscience Corporation较为活跃，换手率分别为16.58%、11.32%、6.52%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Advanced Biomed Inc.、Mainz Biomed N.V.，振幅分别为54.38%、19.86%、15.41%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805031616a6d2e183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805031616a6d2e183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2556894853","title":"Castle Biosciences, Inc.盘中异动 临近收盘股价大跌5.01%报15.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556894853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556894853?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:39","pubTimestamp":1753990759,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时39分，Castle Biosciences, Inc.股票出现异动，股价大幅下跌5.01%。截至发稿，该股报15.28美元/股，成交量23.6679万股，换手率0.82%，振幅5.60%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为1.84%。其相关个股中，Grail, Inc.、Check-Cap Ltd.、精密科学涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、Guardant Health, Inc.较为活跃，换手率分别为21.64%、9.74%、5.58%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Ispecimen Inc.、燃石医学，振幅分别为39.90%、18.57%、12.83%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080103391994c6fe82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080103391994c6fe82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2552125439","title":"Castle Biosciences, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552125439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552125439?lang=zh_cn&edition=full","pubTime":"2025-07-18 02:49","pubTimestamp":1752778143,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日02时49分，Castle Biosciences, Inc.股票出现波动，股价大幅下跌5.14%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为0.90%。其相关个股中，Mdxhealth Sa、Bioaffinity Technologies, Inc.、Exagen Inc.涨幅较大，Applied Dna Sciences, Inc.、Caredx, Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为30.94%、22.61%、9.87%，振幅较大的相关个股有Caredx, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies, Inc.，振幅分别为40.39%、19.92%、17.53%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071802490497aa1c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071802490497aa1c48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2544958439","title":"Castle Biosciences, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544958439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544958439?lang=zh_cn&edition=full","pubTime":"2025-06-17 22:11","pubTimestamp":1750169479,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日22时11分，Castle Biosciences, Inc.股票出现波动，股价急速跳水5.16%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.98%。其相关个股中，Prophase Labs, Inc.、Oncocyte Corporation、Prenetics Global涨幅较大，Prophase Labs, Inc.、Applied Dna Sciences, Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为129.65%、6.41%、0.56%，振幅较大的相关个股有Oncocyte Corporation、Prophase Labs, Inc.、Applied Dna Sciences, Inc.，振幅分别为13.92%、13.74%、7.81%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤、DecisionDx-黑色素瘤，DecisionDx-CMSeq、DecisionDx-PRAME等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061722112097838268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061722112097838268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2518277687","title":"Castle Biosciences, Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277687?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:43","pubTimestamp":1741617807,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时43分，Castle Biosciences, Inc.股票出现异动，股价快速下挫5.29%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.18%。其相关个股中，恩佐生化、Bioaffinity Technologies, Inc.、23Andme Holding Co.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、23Andme Holding Co.较为活跃，换手率分别为6.10%、2.68%、1.93%，振幅较大的相关个股有Inotiv, Inc.、23Andme Holding Co.、Exagen Inc.，振幅分别为20.23%、16.77%、15.17%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤，DecisionDx-黑色素瘤，DecisionDx-CMSeq和DecisionDx-PRAME。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022432798a2aef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022432798a2aef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2518280964","title":"Castle Biosciences, Inc.2024财年实现净利润18.25百万美元，同比增加131.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518280964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518280964?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449618,"startTime":"0","endTime":"0","summary":"3月9日，Castle Biosciences, Inc.公布财报，公告显示公司2024财年净利润为18.25百万美元，同比增加131.76%；其中营业收入为3.32亿美元，同比增加50.91%，每股基本收益为0.66美元。从资产负债表来看，Castle Biosciences, Inc.总负债98.08百万美元，其中短期债务2.04百万美元，资产负债比为0.06，流动比率为0.08。机构评级：截至2025年3月9日，当前有9家机构对Castle Biosciences, Inc.目标价做出预测，其中目标均价为39.67美元，其中最低目标价为36.00美元，最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000029a266b2b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000029a266b2b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL"],"gpt_icon":0},{"id":"1158731355","title":"异动解读 | Castle Biosciences股票盘中大涨5.12% 公司财务数据合理","url":"https://stock-news.laohu8.com/highlight/detail?id=1158731355","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158731355?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:26","pubTimestamp":1741116394,"startTime":"0","endTime":"0","summary":"Castle Biosciences公司股票今日盘中出现较大涨幅,引起了广泛关注。据报道,CSTL股价大涨5.12%,盘中最高达到22.36美元/股,换手率仅1.57%,振幅9.38%,成交量增加。分析人士指出,造成CSTL股价上涨的主要原因可能是公司不久前公布的最新财报数据表现出色。财报显示,CSTL实现营业收入3.32亿美元,净利润1825万美元,每股收益0.66美元,毛利2.59亿美元,市盈率36倍。总的来说,可见CSTL股价上涨与公司自身的业绩表现和融资发展前景密切相关。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Castle Biosciences股票盘中大涨5.12% 公司财务数据合理","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSTL"],"gpt_icon":0},{"id":"2517298864","title":"Castle Biosciences, Inc.盘中异动 股价大涨5.12%报22.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517298864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517298864?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:23","pubTimestamp":1741116233,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时23分，Castle Biosciences, Inc.股票出现异动，股价快速上涨5.12%。截至发稿，该股报22.36美元/股，成交量44.739万股，换手率1.57%，振幅9.38%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.98%。其相关个股中，Neuronetics, Inc.、Grail, Inc.、Opko健康涨幅较大，Ispecimen Inc.、Prophase Labs, Inc.、Neuronetics, Inc.较为活跃，换手率分别为16.91%、7.56%、7.06%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies, Inc.、Biodesix, Inc.，振幅分别为36.22%、34.15%、33.66%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030503235396398941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030503235396398941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2514282320","title":"Castle Biosciences, Inc.盘中异动 早盘急速下跌7.24%报23.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514282320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514282320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Castle Biosciences, Inc.股票出现异动，股价大幅下跌7.24%。截至发稿，该股报23.45美元/股，成交量1.0393万股，换手率0.04%，振幅2.65%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为0.64%。其相关个股中，Oncocyte Corporation、Opko健康、Biodesix, Inc.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、Prophase Labs, Inc.较为活跃，换手率分别为4.28%、0.84%、0.75%，振幅较大的相关个股有Radnet, Inc.、Aclaris Therapeutics, Inc.、Sotera Health Company，振幅分别为8.75%、5.13%、4.64%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223206a2580142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223206a2580142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.castlebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0328},{"period":"1month","weight":0.151},{"period":"3month","weight":0.6401},{"period":"6month","weight":1.1955},{"period":"1year","weight":0.2015},{"period":"ytd","weight":0.4499}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Castle Biosciences, Inc.于2007年9月12日在特拉华州注册成立。该公司是一家商业阶段的皮肤病癌症公司，致力于为医生及其患者提供个性化，临床可操作的基因组信息，以做出更准确的治疗决策。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.030345},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.068437},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.002672},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084405},{"month":5,"riseRate":0.5,"avgChangeRate":0.014411},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.00564},{"month":7,"riseRate":0.666667,"avgChangeRate":0.055356},{"month":8,"riseRate":1,"avgChangeRate":0.247828},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100564},{"month":10,"riseRate":0.428571,"avgChangeRate":0.054309},{"month":11,"riseRate":0.571429,"avgChangeRate":0.067915},{"month":12,"riseRate":0.571429,"avgChangeRate":0.092883}],"exchange":"NASDAQ","name":"Castle Biosciences, Inc.","nameEN":"Castle Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Castle Biosciences, Inc.(CSTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Castle Biosciences, Inc.,CSTL,Castle Biosciences, Inc.股票,Castle Biosciences, Inc.股票老虎,Castle Biosciences, Inc.股票老虎国际,Castle Biosciences, Inc.行情,Castle Biosciences, Inc.股票行情,Castle Biosciences, Inc.股价,Castle Biosciences, Inc.股市,Castle Biosciences, Inc.股票价格,Castle Biosciences, Inc.股票交易,Castle Biosciences, Inc.股票购买,Castle Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Castle Biosciences, Inc.(CSTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}